NCT04728048

Brief Summary

The purpose of this prospective randomized controlled study is to compare the number of physician top-up interventions during the first stage of labour between two different neuraxial analgesia techniques : the dural puncture epidural and the standard epidural.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
130

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 19, 2021

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

January 20, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 28, 2021

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

July 17, 2024

Status Verified

July 1, 2024

Enrollment Period

4.4 years

First QC Date

January 20, 2021

Last Update Submit

July 15, 2024

Conditions

Keywords

Dural puncture epiduralEpiduralLow dose bupivacaine

Outcome Measures

Primary Outcomes (1)

  • Need for 1 physician epidural top-up

    The number of parturients who need at least one physician top-up intervention during the first stage of labour.

    Up to 24 hours after inclusion. From installation of epidural analgesia until the end of first stage of labour defined as full cervix dilation or decision by the attending obstetrician to proceed to a cesarean delivery.

Secondary Outcomes (11)

  • Number of physician epidural top-ups

    Up to 24 hours after inclusion. From installation of epidural analgesia until the end of first stage of labour defined as full cervix dilation or decision by the attending obstetrician to proceed to a cesarean delivery.

  • Timing of physician top-ups

    Up to 24 hours after inclusion. From installation of epidural analgesia until the end of first stage of labour defined as full cervix dilation or decision by the attending obstetrician to proceed to a cesarean delivery.

  • Analgesia scores

    Up to 24 hours after inclusion. From installation of epidural analgesia until the end of first stage of labour defined as full cervix dilation or decision by the attending obstetrician to proceed to a cesarean delivery.

  • Sacral block

    Up to 24 hours after inclusion. From installation of epidural analgesia until the end of first stage of labour defined as full cervix dilation or decision by the attending obstetrician to proceed to a cesarean delivery.

  • Asymetrical block

    Up to 24 hours after inclusion. From installation of epidural analgesia until the end of first stage of labour defined as full cervix dilation or decision by the attending obstetrician to proceed to a cesarean delivery.

  • +6 more secondary outcomes

Study Arms (2)

Dural puncture epidural (group DPE)

EXPERIMENTAL

The epidural space will be identified in the seated position between the L2 and L5 interspaces with a 17G-10 cm Tuohy epidural needle (CHS ®, Oakville, ON, Canada) using a loss of resistance to saline technique. In both groups, a needle-through-needle technique will be performed using a 25G 5-inch Whitacre spinal needle (BD®, Franklin Lakes, NJ, USA). In group DPE, a single dural puncture with confirmation of free-flow CSF will be performed. If there is no free-flow CSF return through the spinal needle, the epidural catheter will be threaded 4-5cm in the epidural space and the patient will still be assigned to the DPE group, as per "intent-to-treat" protocol.

Procedure: Dural puncture epidural

Standard epidural (group EPL)

ACTIVE COMPARATOR

The epidural space will be identified in the seated position between the L2 and L5 interspaces with a 17G-10 cm Tuohy epidural needle (CHS ®, Oakville, ON, Canada) using a loss of resistance to saline technique. In both groups, a needle-through-needle technique will be performed using a 25G 5-inch Whitacre spinal needle (BD®, Franklin Lakes, NJ, USA).In Group EPL, no dural puncture will be performed and the catheter will be threaded 4-5cm in the epidural space.

Procedure: Standard epidural

Interventions

already described

Dural puncture epidural (group DPE)

already described

Standard epidural (group EPL)

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy pregnant women (ASA 1 and 2) requesting epidural analgesia during labour.
  • Primiparous and multiparous parturients at term gestation (37 to 42 weeks).
  • Women 18 years old and older.
  • Administration of epidural analgesia between 7am and 4pm on weekdays.
  • Singleton and vertex presentation foetus.
  • Cervical dilatation ≤ 5 cm.
  • BMI ≤ 40.
  • French speaking

You may not qualify if:

  • Pregnancy diseases such as gestational hypertension, preeclampsia and gestational diabetes.
  • Contraindications to neuraxial analgesia: thrombocytopenia \< 70 x 109/L, spinal cord anomalies, anticoagulation therapy, etc.
  • Known important fetal anomalies.
  • Allergy to any of the medications used in the study.
  • Suspected chorioamnionitis with spontaneous premature rupture of membranes (PROM).
  • Difficulty understanding and speaking French.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CIUSSS de l'Est de l'Île de Montréal

Montreal, Quebec, H1T2M4, Canada

RECRUITING

MeSH Terms

Conditions

Labor Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 20, 2021

First Posted

January 28, 2021

Study Start

January 19, 2021

Primary Completion

June 1, 2025

Study Completion

December 1, 2025

Last Updated

July 17, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations